Menu Back toSession-5-EU-Updates

Pharmacovigilance and Risk Management Strategies Conference


Session 5: EU Updates

    Session Chair(s)
      Mick  Foy

      Mick Foy

      • Group Manager, Vigilance Intelligence and Research Group
      • Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
      Hans-Georg  Eichler, MD, MSc

      Hans-Georg Eichler, MD, MSc

      • Senior Medical Officer
      • European Medicines Agency, European Union, United Kingdom
    Regulations and expectations for pharmacovigilance in the EEA continue to evolve. This session will explore recent developments related to postmarketing pharmacovigilance as well as the practice of drug safety during clinical trials. The focus will be on the evolving situation in the EEA, set in a global context.
    Speaker(s)
      Mick  Foy

      Speaker

      Mick Foy

      • Group Manager, Vigilance Intelligence and Research Group
      • Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
      Vicki  Edwards, RPh

      Speaker

      Vicki Edwards, RPh

      • Vice President, Pharmacovigilance Excellence and QPPV
      • AbbVie, Inc., United Kingdom
      Valerie E. Simmons, MD, FFPM

      Speaker

      Valerie E. Simmons, MD, FFPM

      • EU QPPV, Global Patient Safety
      • Eli Lilly and Company Ltd, United Kingdom